{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:56:27Z","timestamp":1788494187603,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:00:00Z","timestamp":1666051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s13555-022-00828-5","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T06:02:51Z","timestamp":1666072971000},"page":"2765-2779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pooled Safety Analysis of Baricitinib in Adult Participants with Atopic Dermatitis in the Japanese Subpopulation from Six Randomized Clinical Trials"],"prefix":"10.1007","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct02576938","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03334396","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03334422","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03428100","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03733301","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03334435","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Norito","family":"Katoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Takita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3200-2882","authenticated-orcid":false,"given":"Hitoe","family":"Torisu-Itakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehisa","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,18]]},"reference":[{"key":"828_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2332\/allergolint.14-RAI-0769","volume":"63","author":"I Katayama","year":"2014","unstructured":"Katayama I, Kohno Y, Akiyama K, et al. Japanese guideline for atopic dermatitis 2014. Allergol Int. 2014;63:377\u201398.","journal-title":"Allergol Int"},{"key":"828_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1046\/j.1365-2133.2003.05092.x","volume":"148","author":"T Muto","year":"2003","unstructured":"Muto T, Hsieh SD, Sakurai Y, et al. Prevalence of atopic dermatitis in Japanese adults. Br J Dermatol. 2003;148:117\u201321.","journal-title":"Br J Dermatol"},{"key":"828_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jdermsci.2009.04.004","volume":"55","author":"H Saeki","year":"2009","unstructured":"Saeki H, Oiso N, Honma M, Iizuka H, Kawada A, Tamaki K. Prevalence of atopic dermatitis in Japanese adults and community validation of the UK diagnostic criteria. J Dermatol Sci. 2009;55:140\u20131.","journal-title":"J Dermatol Sci"},{"key":"828_CR4","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"S Barbarot","year":"2018","unstructured":"Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018;73:1284\u201393.","journal-title":"Allergy"},{"key":"828_CR5","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jaci.2015.08.015","volume":"136","author":"S Noda","year":"2015","unstructured":"Noda S, Su\u00e1rez-Fari\u00f1as M, Ungar B, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol. 2015;136:1254\u201364.","journal-title":"J Allergy Clin Immunol"},{"key":"828_CR6","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1038\/jid.2010.218","volume":"130","author":"R Osawa","year":"2010","unstructured":"Osawa R, Konno S, Akiyama M, et al. Japanese-specific filaggrin gene mutations in Japanese patients suffering from atopic eczema and asthma. J Invest Dermatol. 2010;130:2834\u20136.","journal-title":"J Invest Dermatol"},{"key":"828_CR7","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/jdv.17278","volume":"35","author":"A Wollenberg","year":"2021","unstructured":"Wollenberg A, Nakahara T, Maari C, et al. Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 phase 3 randomized trial. J Eur Acad Dermatol Venereol. 2021;35:1543\u201352.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"828_CR8","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaad.2018.01.018","volume":"80","author":"E Guttman-Yassky","year":"2019","unstructured":"Guttman-Yassky E, Silverberg JI, Nemoto O, et al. Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study. J Am Acad Dermatol. 2019;80:913-21.e9.","journal-title":"J Am Acad Dermatol"},{"key":"828_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/bjd.18898","volume":"183","author":"EL Simpson","year":"2020","unstructured":"Simpson EL, Lacour JP, Spelman L, et al. Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. Br J Dermatol. 2020;183:242\u201355.","journal-title":"Br J Dermatol"},{"key":"828_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/jdv.16948","volume":"35","author":"T Bieber","year":"2021","unstructured":"Bieber T, Thyssen JP, Reich K, et al. Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials. J Eur Acad Dermatol Venereol. 2021;35:476\u201385.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"828_CR11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jid.2017.01.030","volume":"137","author":"SM Langan","year":"2017","unstructured":"Langan SM, Abuabara K, Henrickson SE, Hoffstad O, Margolis DJ. Increased risk of cutaneous and systemic infections in atopic dermatitis: a cohort study. J Invest Dermatol. 2017;137:1375\u20137.","journal-title":"J Invest Dermatol"},{"key":"828_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/14397595.2019.1583711","volume":"30","author":"M Harigai","year":"2020","unstructured":"Harigai M, Takeuchi T, Smolen JS, et al. Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: an integrated analysis of Phases 2 and 3 trials. Mod Rheumatol. 2020;30:36\u201343.","journal-title":"Mod Rheumatol"},{"key":"828_CR13","unstructured":"The Japanese Dermatological Association. Guidelines for the management of atopic dermatitis 2021. https:\/\/www.dermatol.or.jp\/uploads\/uploads\/files\/guideline\/ADGL2021.pdf. Accessed 20 Jan 2022."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00828-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-022-00828-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-022-00828-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T15:47:41Z","timestamp":1668786461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-022-00828-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,18]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["828"],"URL":"https:\/\/doi.org\/10.1007\/s13555-022-00828-5","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,18]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}